Federica Zarrilli

Prof. Federica Zarrilli

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
SKSimona Keller
Simona Keller
Marco SarchiaponeMarco Sarchiapone
Marco Sarchiapone
FZFederica Zarrilli
Federica Zarrilli
AVAlja Videtič
Alja Videtič
Angelo FerraroAngelo Ferraro
Angelo Ferraro
Lorenzo ChiariottiLorenzo Chiariotti
Lorenzo Chiariotti
Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, plays a key role in the development and survival of neurons in the central nervous system.1 BDNF binds to a specific tyrosine kinase receptor (tropomyosin-related kinase B receptor [trkB]) and regulates many functions related to neuron development such as neurite outgrowth, synthesis of differentiating factors, and morphological plasticity.1 In adulthood, BDNF is involved in neural homeostasis and in processes related to neuronal plasticity and connectivity, including learning and memory,2,3 drug addiction,4 response to social stress, aggressiveness, and anxietylike behaviors.5,6 Alteration of BDNF expression in specific neurons may reduce neural plasticity, therefore impairing the ability to respond to stressors, and contributes to different neurodegenerative and neuropsychiatric disorders including depression and bipolar disorder.7 Single-nucleotide polymorphisms of the BDNF gene have also been associated, although with conflicting results, with different psychiatric conditions, including schizophrenia and suicidal behavior.8-10

1 December 2002 in Stroke
Verified
Journal Article
Closed access
PDF file
MMMario De Michele
Mario De Michele
SPSalvatore Panico
Salvatore Panico
AIArcangelo Iannuzzi
Arcangelo Iannuzzi
ECEgidio Celentano
Egidio Celentano
ACAnna V. Ciardullo
Anna V. Ciardullo
PRPaolo Rubba
Paolo Rubba
Background and Purpose— The association between obesity and atherosclerotic disease is controversial. In the present analysis, we evaluated whether common carotid intima-media thickness (IMT) and area, 2 markers of preclinical atherosclerosis, were increased in obese subjects. Methods— More than 5000 middle-aged women (n=5062; age, 30 to 69 years) living in the area of Naples, Southern Italy, were recruited for a prospective, currently ongoing study on the etiology of cardiovascular disease and cancer in the female population (the Progetto ATENA study). A subsample of 310 participants underwent high-resolution B-mode ultrasound examination, and the IMTs, intima-media areas, and lumen diameters of common carotid arteries were measured with a semiautomated computerized program. Subjects were divided into 3 groups on the basis of the recently published obesity guidelines for body mass index (BMI), a marker of general obesity, and tertiles of waist-to-hip ratio (WHR), a marker of regional obesity. Results— Women with a BMI ≥30 kg/m 2 showed higher systolic and diastolic blood pressures, triglycerides, and fasting glucose and insulin, as well as lower high-density lipoprotein concentrations, than subjects with lower BMI. A gradual increase in common carotid IMT and intima-media area was observed when lean women (0.94±0.01 mm and 19.8±0.5 mm 2 , respectively) were compared with overweight (0.98±0.01 mm and 21.0±0.4 mm 2 ) and obese (1.02±0.02 mm and 22.6±0.8 mm 2 , P 0.85) had adverse risk factor profiles and thicker carotid intima-media complex than those in the first 2 tertiles ( P <0.01 and P <0.05 for IMT and intima-media area, respectively). In multivariate analyses, BMI and WHR were significant predictors of carotid wall thickness, independently of other traditional and nontraditional cardiovascular risk factors (age, blood pressure, lipid abnormalities, fasting insulin). Conclusions— The present results indicate a graded and independent association between general and abdominal obesity—reflected by high BMI and WHR—and carotid artery wall thickening in a population of middle-aged women.

1 November 2004 in Clinical Chemistry
Verified
Journal Article
Closed access
PDF file
GFGiuliana Fortunato
Giuliana Fortunato
EMElio Marciano
Elio Marciano
FZFederica Zarrilli
Federica Zarrilli
Cristina MazzaccaraCristina Mazzaccara
Cristina Mazzaccara
MIMariano Intrieri
Mariano Intrieri
LSLucia Sacchetti
Lucia Sacchetti
Background: Noise-induced cochlear epithelium damage can cause hearing loss in industrial workers. In experimental systems, noise induces the release of free radicals and may damage the cochlear sensorial epithelium. Therefore, genes involved in regulating the reactive oxygen species manganese-superoxide dismutase (SOD2) and the antioxidant paraoxonase (PON) could influence cochlea vulnerability to noise. We evaluated whether susceptibility to noise-induced hearing loss (NIHL) is associated with SOD2, PON1, and PON2 polymorphisms in workers exposed to prolonged loud noise.

13 October 2017 in Beneficial Microbes
Verified
Journal Article
Closed access
AEA. Elce
A. Elce
FAF. Amato
F. Amato
FZFederica Zarrilli
Federica Zarrilli
ACA. Calignano
A. Calignano
RTR. Troncone
R. Troncone
RCRoberto Berni Canani
Roberto Berni Canani
Butyrate acts as energy source for intestinal epithelial cells and as key mediator of several immune processes, modulating gene expression mainly through histone deacetylation inhibition. Thanks to these effects, butyrate has been proposed for the treatment of many intestinal diseases. Aim of this study was to investigate the effect of butyrate on the expression of a large series of target genes encoding proteins involved in pro-inflammatory pathways. We performed quantitative real-time-PCR analysis of the expression of 86 genes encoding proteins bearing to pro-inflammatory pathways, before and after butyrate exposure, in primary epithelial cells derived from human small intestine and colon. Butyrate significantly down-regulated the expression of genes involved in inflammatory response, among which nuclear factor kappa beta, interferon-gamma, Toll like 2 receptor and tumour necrosis factor-alpha. Further confirmations of these data, including studies at protein level, would support the use of butyrate as effective therapeutic strategy in intestinal inflammatory disorders.

26 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FAFelice Amato
Felice Amato
MSManuela Seia
Manuela Seia
SGSonia Giordano
Sonia Giordano
Ausilia ElceAusilia Elce
Ausilia Elce
FZFederica Zarrilli
Federica Zarrilli
Rossella TomaiuoloRossella Tomaiuolo
Rossella Tomaiuolo
Cystic fibrosis (CF) is the most frequent lethal genetic disorder among Caucasians. It depends on alterations of a chloride channel expressed by most epithelial cells and encoded by CFTR gene. Also using scanning techniques to analyze the whole coding regions of CFTR gene, mutations are not identified in up to 10% of CF alleles, and such figure increases in CFTR-related disorders (CFTR-RD). Other gene regions may be the site of causing-disease mutations. We searched for genetic variants in the 1500 bp of CFTR 3′ untranslated region, typical target of microRNA (miRNA) posttranscriptional gene regulation, in either CF patients with the F508del homozygous genotype and different clinical expression (n = 20), CF (n = 32) and CFTR-RD (n = 43) patients with one or none mutation after CFTR scanning and in controls (n = 50). We identified three SNPs, one of which, the c.*1043A>C, was located in a region predicted to bind miR-433 and miR-509-3p. Such mutation was peculiar of a CFTR-RD patient that had Congenital Bilateral Absence of Vas Deferens (CBAVD), diffuse bronchiectasis, a borderline sweat chloride test and the heterozygous severe F508del mutation on the other allele. The expression analysis demonstrated that the c.*1043A>C increases the affinity for miR-509-3p and slightly decreases that for the miR-433. Both miRNAs cause in vitro a reduced expression of CFTR protein. Thus, the c.*1043A>C may act as a mild CFTR mutation enhancing the affinity for inhibitory miRNAs as a novel pathogenetic mechanism in CF.

13 October 2016 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
VTVito Terlizzi
Vito Terlizzi
GCGiuseppe Castaldo
Giuseppe Castaldo
DSDonatello Salvatore
Donatello Salvatore
MLMarco Lucarelli
Marco Lucarelli
VRValeria Raia
Valeria Raia
FAFelice Amato
Felice Amato
Background The effect of complex alleles in cystic fibrosis (CF) is poorly defined for the lack of functional studies. Objectives To describe the genotype–phenotype correlation and the results of either in vitro and ex vivo studies performed on nasal epithelial cells (NEC) in a cohort of patients with CF carrying cystic fibrosis transmembrane conductance regulator (CFTR) complex alleles. Methods We studied 70 homozygous, compound heterozygous or heterozygous for CFTR mutations: p.[Arg74Trp;Val201Met;Asp1270Asn], n=8; p.[Ile148Thr;Ile1023_Val1024del], n=5; p.[Arg117Leu;Leu997Phe], n=6; c.[1210-34TG[12];1210-12T[5];2930C>T], n=3; p.[Arg74Trp;Asp1270Asn], n=4; p.Asp1270Asn, n=2; p.Ile148Thr, n=6; p.Leu997Phe, n=36. In 39 patients, we analysed the CFTR gating activity on NEC in comparison with patients with CF (n=8) and carriers (n=4). Finally, we analysed in vitro the p.[Arg74Trp;Val201Met;Asp1270Asn] complex allele. Results The p.[Ile148Thr;Ile1023_Val1024del] caused severe CF in five compound heterozygous with a class I–II mutation. Their CFTR activity on NEC was comparable with patients with two class I–II mutations (mean 7.3% vs 6.9%). The p.[Arg74Trp;Asp1270Asn] and the p.Asp1270Asn have scarce functional effects, while p.[Arg74Trp;Val201Met;Asp1270Asn] caused mild CF in four of five subjects carrying a class I–II mutation in trans, or CFTR-related disorders (CFTR-RD) in three having in trans a class IV–V mutation. The p.[Arg74Trp;Val201Met;Asp1270Asn] causes significantly (pT] and a class I–II mutation had mild CF or CFTR-RD (gating activity: 18.5–19.0%). Conclusions The effect of complex alleles partially depends on the mutation in trans. Although larger studies are necessary, the CFTR activity on NEC is a rapid contributory tool to classify patients with CFTR dysfunction.